Comparison of microencapsulation techniques for the water-soluble drugs nitenpyram and clomipramine HC1

Journal of Controlled Release

Volumn 85, Issue 1-3, 2002, Pages 35-43

  Wieland Berghausen, Susanne ^a,b   Schote, Uwe ^a   Frey, Michaela ^a   Schmidt, Friederike ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b WRO 1058564   (Switzerland)

Author keywords

Coacervation; Film coating; Microencapsulation; Solvent evaporation; Stability of drug substance

Indexed keywords

CLOMIPRAMINE; INSECTICIDE; NITENPYRAM; SURFACTANT; UNCLASSIFIED DRUG; WATER;

ARTICLE; COACERVATION; EMULSION; EVAPORATION; FILM COATING; MICROENCAPSULATION; PRIORITY JOURNAL; SOLUBILITY;

CLOMIPRAMINE; DRUG COMPOUNDING; PYRIDINES; SOLUBILITY; WATER;

EID: 0037073783     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00269-9     Document Type: Article

References (31)

1. Kondo A. van Valkenburg J.W. Microcapsule Processing and Technology. I:1979;Marcel Dekker, New York.
2. Gutcho M.H. Microcapsules and Other Capsules. I:1979;Noyses Data Corporation, Park Ridge, New Jersey.
3. O'Donnell P.B., McGinity J.W. Preparation of microspheres by solvent evaporation technique. Adv. Drug Delivery Rev. 28:1997;25-42.
4. Bodmeier R., Wang H., Hermann J. Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique. STP Pharma. Sci. 4:(4):1994;275-281.
5. R.E. Miller, J.L. Anderson, Encapsulation Process and its Products, US Patent 3, 155, 590, 3rd November, 1964.
6. Uddin M.S., Hawlader M.N.A., Zhu H.J. Microencapsulation of ascorbic acid: Effect of process variables on product characteristics. J. Microencapsul. 18:(2):2001;199-209.
7. Yoshiyuki K., Hirata G., Samejima M. Studies on microcapsules II: influence of molecular weight of ethylcellulose in the microencapsulation of ascorbic acid. Chem. Pharm. Bull. 31:1983;4476-4482.
8. Benita S., Donbrow M. Effect of polyisobutylene on ethylcellulose-walled microcapsules: Wall structure and thickness of Salicylamide and Theophylline microcapsules. J. Pharm. Sci. 71:(2):1982;205-210.
9. Yalabik-Kas H.S. Microencapsulation and in vitro dissolution of oxazepam from ethylcellulose microcapsules. Drug. Dev. Ind. Pharm. 9:(6):1983;1047-1060.
10. Bodmeier R., McGinity J.W. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by solvent evaporation method. Pharm. Res. 4:1987;465-471.
11. Cavalier M., Benoit J.P., Thies C. The formation and characterization of hydrocortisone-loaded poly((+)lactide) microspheres. J. Pharm. Pharmacol. 38:1986;249-253.
12. Kyo M., Hyon S.H., Ikada Y. Effects of preparation conditions of cisplatin-loaded microspheres on the in vitro release. J. Controlled Release. 35:1995;73-82.
13. Soriano I., Delgado A., Kellaway I., Evora C. Effect of surfactant agents on the in vitro release of insulin from DL-PLA microspheres. Drug Dev. Ind. Pharm. 22:(9-10):1996;1009-1012.
14. Blanco-Prieto M.J., Leo E., Delie F., Gulik A., Gouvreur P., Fattal E. Study of the influence of several stabilizing agents on the entrapment and in vitro release of pBC 264 from poly(lactide-coglycolide) microspheres prepared by a w/o/w solvent evaporation method. Pharm. Res. 13:1996;1127-1129.
15. Lehmann K. Polyamethacrylate in der Pharmazie. Deutsche Apotheker-Zeitung. 1:1984;113-122.
16. McGinity J. Aqueous polymeric coatings for Pharmaceutical Dosage Forms. Drugs Pharm. Sci. 36:1988;152-245.
17. Lehmann K., Petereit H.U. Filmüberzüge auf Basis wässriger Polymethacrylat-dispersionen mit verzögertem Zerfall im Darmbereich. Pharm. Ind. 55:(6):1993;615-618.
18. Lehmann K., Dreher D. Mixtures of Aqueous Poly(meth)acrylate Dispersions for Drug Coating. Pharm. Ind. 48:(19):1986;1182-1183.
19. Buhrer H.G., Hofstetter D. Optimisation of a chemical reaction by means of LabMax (R) and STAVEX. Chimia. 53:(6):1999;287-290.
20. Donbrow M., Benita S. The effect of polyisobutylene on the coacervation of ethylcellulose and the formation of microcapsules. J. Pharm. Pharmacol. 29:1977;4P.
21. Ndesendo V.M.K., Meixner W., Kosatko W., Korsatko-Wabnegg B. Microencapsulation of chloroquine disphosphate by Eudragit RS 100. J. Microencapsul. 13:(1):1996;1-8.
22. M. Samejima, G. Hirata, T. Ishibashi, Process for free-flowing ethylcellulose microcapsules, EP Patent 0099109, 17th September, 1985.
23. Samejima M., Hirata G., Koida Y., Studies on microcapsules I. Role and effect of coacervation-inducing agents in the microencapsulation of ascorbic acid by phase separation method. Chem. Pharm. Bull. 30:(8):1982;2894-2899.
24. Tirkonnen S., Paronen P. Enhancement of drug release from ethylcellulose microcapsules using solid sodium chloride in the wall. Int. J. Pharm. 88:1992;39-51.
25. Oya Alpar H., Walters V. The prolongation of in vitro dissolution of a soluble drug (phenethicillin potassium) by microencapsulation with ethyl cellulose. J. Pharm. Pharmacol. 33:1980;419-422.
26. Chemtob C., Chaumeil J.C., N'Dongo M. Microencapsulation by ethylcellulose phase separation: microcapsule characteristics. Int. J. Pharm. 29:1986;1-7.
27. Chukwu A., Agarwal S.P., Adikwu M.U. Some properties of chlorquine phosphate and quinine hydrochloride microcapsules. STP Pharma. Sci. 1:(2):1991;117-120.
28. Deasy P.B., Brophy M.R., Ecanov B., Joy M.M. Effect of ethylcellulose grade and sealant treatments on the production and in vitro release of microencapsulated sodium salicylate. J. Pharm. Pharmacol. 32:1980;15-20.
29. Goto S., Ushida T., Aoyama T. Preparation and biopharmaceutical evaluation of microcapsules of ampicillin. J. Pharmacobio.-Dynam. 8:1985;270-277.
30. Singh J., Robinson D.H. Controlled release captopril microcapsules: Effect of ethyl cellulose viscosity grade on the in vitro dissolution from microcapsules and tableted microcapsules. J. Microencapsul. 7:(1):1990;67-76.
31. Goto S., Kawata M., Nakamura M., Maekawa K., Aoyama T. Eudragit E, L and S (acrylic resins) microcapsules as pH sensitive release preparations of ketoprofen. J. Microencapsul. 3:(4):1986;305-316.